Adam Scott Levy - 14 Feb 2023 Form 4 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Role: CFO, Chief Bus. Off. and Secy.
Signature: /s/ Adam Levy
Issuer symbol: MLYS
Transactions as of: 14 Feb 2023
Net transactions value: +$100,000
Form type: 4
Filing time: 16 Feb 2023, 15:54:40 UTC
Previous filing: 09 Feb 2023
Next filing: 21 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MLYS	Common Stock	Purchase	$100,000	+6,250	+1.8%	$16.00	350,811	14 Feb 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.